356 related articles for article (PubMed ID: 12887919)
1. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.
Seo DW; Li H; Guedez L; Wingfield PT; Diaz T; Salloum R; Wei BY; Stetler-Stevenson WG
Cell; 2003 Jul; 114(2):171-80. PubMed ID: 12887919
[TBL] [Abstract][Full Text] [Related]
2. TIMP-2 disrupts FGF-2-induced downstream signaling pathways.
Seo DW; Kim SH; Eom SH; Yoon HJ; Cho YR; Kim PH; Kim YK; Han JW; Diaz T; Wei BY; Stetler-Stevenson WG
Microvasc Res; 2008 Nov; 76(3):145-51. PubMed ID: 18721821
[TBL] [Abstract][Full Text] [Related]
3. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro.
Park HY; Kwon HM; Lim HJ; Hong BK; Lee JY; Park BE; Jang Y; Cho SY; Kim HS
Exp Mol Med; 2001 Jun; 33(2):95-102. PubMed ID: 11460888
[TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition.
Hoegy SE; Oh HR; Corcoran ML; Stetler-Stevenson WG
J Biol Chem; 2001 Feb; 276(5):3203-14. PubMed ID: 11042184
[TBL] [Abstract][Full Text] [Related]
5. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells.
Seo DW; Li H; Qu CK; Oh J; Kim YS; Diaz T; Wei B; Han JW; Stetler-Stevenson WG
J Biol Chem; 2006 Feb; 281(6):3711-21. PubMed ID: 16326706
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway.
Kim SH; Cho YR; Kim HJ; Oh JS; Ahn EK; Ko HJ; Hwang BJ; Lee SJ; Cho Y; Kim YK; Stetler-Stevenson WG; Seo DW
Blood; 2012 Dec; 120(24):4892-902. PubMed ID: 23074279
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
8. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo.
Seo DW; Saxinger WC; Guedez L; Cantelmo AR; Albini A; Stetler-Stevenson WG
Peptides; 2011 Sep; 32(9):1840-8. PubMed ID: 21871510
[TBL] [Abstract][Full Text] [Related]
9. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
[TBL] [Abstract][Full Text] [Related]
11. Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix.
Collen A; Hanemaaijer R; Lupu F; Quax PH; van Lent N; Grimbergen J; Peters E; Koolwijk P; van Hinsbergh VW
Blood; 2003 Mar; 101(5):1810-7. PubMed ID: 12393408
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis.
Liu ZJ; Shirakawa T; Li Y; Soma A; Oka M; Dotto GP; Fairman RM; Velazquez OC; Herlyn M
Mol Cell Biol; 2003 Jan; 23(1):14-25. PubMed ID: 12482957
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation.
Guo DQ; Wu LW; Dunbar JD; Ozes ON; Mayo LD; Kessler KM; Gustin JA; Baerwald MR; Jaffe EA; Warren RS; Donner DB
J Biol Chem; 2000 Apr; 275(15):11216-21. PubMed ID: 10753929
[TBL] [Abstract][Full Text] [Related]
14. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
15. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
16. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK.
Oh J; Seo DW; Diaz T; Wei B; Ward Y; Ray JM; Morioka Y; Shi S; Kitayama H; Takahashi C; Noda M; Stetler-Stevenson WG
Cancer Res; 2004 Dec; 64(24):9062-9. PubMed ID: 15604273
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
Fernández CA; Butterfield C; Jackson G; Moses MA
J Biol Chem; 2003 Oct; 278(42):40989-95. PubMed ID: 12900406
[TBL] [Abstract][Full Text] [Related]
18. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway.
Ardi VC; Van den Steen PE; Opdenakker G; Schweighofer B; Deryugina EI; Quigley JP
J Biol Chem; 2009 Sep; 284(38):25854-66. PubMed ID: 19608737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
